{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:03:19Z","timestamp":1768251799873,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.xphs.2018.07.017","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T02:38:39Z","timestamp":1532486319000},"page":"316-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In\u00a0Vivo Permeability Values"],"prefix":"10.1016","volume":"108","author":[{"given":"Omri","family":"Wolk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milica","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Porat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noa","family":"Fine-Shamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moran","family":"Zur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avital","family":"Beig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arik","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2018.07.017_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A\u00a0theoretical basis for a biopharmaceutic drug classification: the correlation of in\u00a0vitro drug product dissolution and in\u00a0vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.017_bib2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1208\/s12248-016-9877-2","article-title":"BCS biowaivers: similarities and\u00a0differences among EMA, FDA, and WHO requirements","volume":"18","author":"Davit","year":"2016","journal-title":"AAPS J"},{"issue":"7","key":"10.1016\/j.xphs.2018.07.017_bib3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1023\/A:1016473601633","article-title":"Biopharmaceutics Classification System: the scientific basis for biowaiver extensions","volume":"19","author":"Yu","year":"2002","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2018.07.017_bib4","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/mp300140h","article-title":"The fraction dose absorbed, in humans, and high jejunal human permeability relationship","volume":"9","author":"Dahan","year":"2012","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.017_bib5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12248-009-9144-x","article-title":"Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs","volume":"11","author":"Dahan","year":"2009","journal-title":"AAPS J"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.07.017_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2016.11.063","article-title":"Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities","volume":"519","author":"Hens","year":"2017","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2018.07.017_bib7","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2018.07.017_bib8","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/mp100175a","article-title":"High-permeability criterion for BCS classification: segmental\/pH dependent permeability considerations","volume":"7","author":"Dahan","year":"2010","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2018.07.017_bib9","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1021\/acs.molpharmaceut.6b00514","article-title":"Regional intestinal permeability of three model drugs in human","volume":"13","author":"Dahlgren","year":"2016","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2018.07.017_bib10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.2042-7158.1997.tb06084.x","article-title":"Human jejunal effective permeability and its correlation with preclinical drug absorption models","volume":"49","author":"Lennernas","year":"1997","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"10-11","key":"10.1016\/j.xphs.2018.07.017_bib11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/00498250701704819","article-title":"Intestinal permeability and its relevance for absorption and elimination","volume":"37","author":"Lennernas","year":"2007","journal-title":"Xenobiotica"},{"issue":"11","key":"10.1016\/j.xphs.2018.07.017_bib12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.addr.2007.06.016","article-title":"Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in\u00a0vivo","volume":"59","author":"Lennernas","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp4003392","article-title":"Human in\u00a0vivo regional intestinal permeability: importance for pharmaceutical drug development","volume":"11","author":"Lennernas","year":"2014","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2018.07.017_bib14","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1124\/dmd.109.028282","article-title":"Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine","volume":"37","author":"Dahan","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.xphs.2018.07.017_bib15","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/dmd.108.020859","article-title":"Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats","volume":"36","author":"MacLean","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.xphs.2018.07.017_bib16","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1023\/A:1026183200740","article-title":"P-glycoprotein increases from proximal to distal regions of human small intestine","volume":"20","author":"Mouly","year":"2003","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2125.2005.02389.x","article-title":"Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract","volume":"60","author":"Thorn","year":"2005","journal-title":"Br J Clin Pharmacol"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.07.017_bib18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2015.05.002","article-title":"The biopharmaceutics of successful controlled release drug product: segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract","volume":"489","author":"Zur","year":"2015","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2018.07.017_bib19","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1021\/mp500152y","article-title":"The low\/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol","volume":"11","author":"Zur","year":"2014","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.017_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/js970332a","article-title":"Human intestinal permeability","volume":"87","author":"Lennernas","year":"1998","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2018.07.017_bib21","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/mp500834v","article-title":"Human in\u00a0vivo regional intestinal permeability: quantitation using site-specific drug absorption data","volume":"12","author":"Sj\u00f6gren","year":"2015","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2018.07.017_bib22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1023\/A:1011020025338","article-title":"Human jejunal permeability of two polar drugs: cimetidine and ranitidine","volume":"18","author":"Takamatsu","year":"2001","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.xphs.2018.07.017_bib23","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1023\/A:1012134219095","article-title":"Human intestinal permeability of piroxicam, propranolol, phenylalanine, and PEG 400 determined by jejunal perfusion","volume":"14","author":"Takamatsu","year":"1997","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.017_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/17425255.1.2.325","article-title":"The rise of PAMPA","volume":"1","author":"Avdeef","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.xphs.2018.07.017_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejps.2018.04.016","article-title":"Drug permeability profiling using cell-free permeation tools: overview and applications","volume":"119","author":"Berben","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2018.07.017_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejps.2015.06.023","article-title":"Modification of a PAMPA model to predict passive gastrointestinal absorption and plasma protein binding","volume":"77","author":"Bujard","year":"2015","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2018.07.017_bib27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1055\/s-0042-101247","article-title":"Prediction of the passive intestinal absorption of medicinal plant extract constituents with the Parallel Artificial Membrane Permeability Assay (PAMPA)","volume":"82","author":"Petit","year":"2016","journal-title":"Planta Med"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.017_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.2042-7158.2011.01391.x","article-title":"Everted gut sac model as a tool in pharmaceutical research: limitations and applications","volume":"64","author":"Alam","year":"2012","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.017_bib29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jsps.2013.03.006","article-title":"Enhanced solubility and intestinal absorption of candesartan cilexetil solid dispersions using everted rat intestinal sacs","volume":"22","author":"Gurunath","year":"2014","journal-title":"Saudi Pharm J"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.017_bib30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.2042-7158.2011.01434.x","article-title":"Absorption enhancement studies of clopidogrel hydrogen sulphate in rat everted gut sacs","volume":"64","author":"Lassoued","year":"2012","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.017_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1528-1167.2012.03409.x","article-title":"Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique","volume":"53","author":"Fortuna","year":"2012","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.xphs.2018.07.017_bib32","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3109\/03639045.2012.714787","article-title":"An improved prediction of the human in\u00a0vivo intestinal permeability and BCS class of drugs using the in\u00a0vitro permeability ratio obtained for rat intestine using an Ussing chamber system","volume":"39","author":"Li","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2018.07.017_bib33","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/acs.molpharmaceut.7b00279","article-title":"Regional intestinal permeability in rats: a comparison of methods","volume":"14","author":"Roos","year":"2017","journal-title":"Mol Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.07.017_bib34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejps.2012.10.007","article-title":"Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique","volume":"48","author":"Sjoberg","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/0471140856.tx2006s47","article-title":"Caco-2 Cells as a model for intestinal absorption","volume":"47","author":"Angelis","year":"2011","journal-title":"Curr Protoc Toxicol"},{"key":"10.1016\/j.xphs.2018.07.017_bib36","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11095-017-2331-z","article-title":"Closed-loop Doluisio (colon, small intestine) and single-pass intestinal perfusion (colon, jejunum) in rat-biophysical model and predictions based on Caco-2","volume":"35","author":"Lozoya-Agullo","year":"2017","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.017_bib38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejpb.2012.02.012","article-title":"Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption","volume":"81","author":"Beig","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/mp800088f","article-title":"Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs","volume":"6","author":"Dahan","year":"2009","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.017_bib40","doi-asserted-by":"crossref","first-page":"G371","DOI":"10.1152\/ajpgi.00102.2009","article-title":"Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting","volume":"297","author":"Dahan","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.xphs.2018.07.017_bib41","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/mp200181v","article-title":"The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation","volume":"8","author":"Miller","year":"2011","journal-title":"Mol Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.07.017_bib42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2016.09.061","article-title":"Segmental-dependent permeability throughout the small intestine following oral drug administration: single-pass vs. Doluisio approach to in-situ rat perfusion","volume":"515","author":"Lozoya-Agullo","year":"2016","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.07.017_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2017.05.018","article-title":"Investigating drug absorption from the colon: single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusion","volume":"527","author":"Lozoya-Agullo","year":"2017","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.07.017_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.01.014","article-title":"In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: investigation of the single-pass vs. the Doluisio experimental approaches","volume":"480","author":"Lozoya-Agullo","year":"2015","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2018.07.017_bib45","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1021\/mp400485k","article-title":"Purely in silico BCS classification: science based quality standards for the world's drugs","volume":"10","author":"Dahan","year":"2013","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.017_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/bdd.2072","article-title":"Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon","volume":"38","author":"Pade","year":"2017","journal-title":"Biopharm Drug Dispos"},{"issue":"6","key":"10.1016\/j.xphs.2018.07.017_bib47","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/mp4000585","article-title":"Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number","volume":"10","author":"Pham-The","year":"2013","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2018.07.017_bib48","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1021\/mp0600182","article-title":"A\u00a0provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan","volume":"3","author":"Takagi","year":"2006","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2018.07.017_bib49","first-page":"1563","article-title":"Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development","volume":"8","author":"Wolk","year":"2014","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.017_bib50","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s11095-008-9789-7","article-title":"Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein","volume":"26","author":"Dahan","year":"2009","journal-title":"Pharm Res"},{"issue":"2-3","key":"10.1016\/j.xphs.2018.07.017_bib51","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejps.2008.10.013","article-title":"Segmental-dependent membrane permeability along the intestine following oral drug administration: evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat","volume":"36","author":"Dahan","year":"2009","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.017_bib52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1208\/s12248-013-9462-x","article-title":"Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine","volume":"15","author":"Fairstein","year":"2013","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib53","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/mp500553b","article-title":"Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification","volume":"12","author":"Ozawa","year":"2015","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.017_bib54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1208\/pt040216","article-title":"Implications of density correction in gravimetric method for water flux determination using rat single-pass intestinal perfusion technique: a technical note","volume":"4","author":"Issa","year":"2003","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.017_bib55","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/jpet.301.2.586","article-title":"Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in rat","volume":"301","author":"Li","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.xphs.2018.07.017_bib56","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/bmc.3095","article-title":"Quantification of carbamazepine and its 10,11-epoxide metabolite in rat plasma by UPLC-UV and application to pharmacokinetic study","volume":"28","author":"Beig","year":"2014","journal-title":"Biomed Chromatogr"},{"issue":"6","key":"10.1016\/j.xphs.2018.07.017_bib57","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1021\/acs.molpharmaceut.7b00275","article-title":"Toward successful cyclodextrin based solubility-enabling formulations for oral delivery of lipophilic drugs: solubility\u2013permeability trade-off, biorelevant dissolution, and the unstirred water layer","volume":"14","author":"Fine-Shamir","year":"2017","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.017_bib58","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1208\/s12248-017-0052-1","article-title":"Advantageous solubility-permeability interplay when using amorphous solid dispersion (ASD) formulation for the BCS class IV P-gp substrate rifaximin: simultaneous increase of both the solubility and the permeability","volume":"19","author":"Beig","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.xphs.2018.07.017_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejpb.2017.09.012","article-title":"Concomitant solubility-permeability increase: vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposide","volume":"121","author":"Beig","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/acs.molpharmaceut.6b00967","article-title":"Striking the optimal solubility\u2013permeability balance in oral formulation development for lipophilic drugs: maximizing carbamazepine blood levels","volume":"14","author":"Beig","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2018.07.017_bib61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.addr.2016.04.018","article-title":"The solubility\u2013permeability interplay and oral drug formulation design: two heads are better than one","volume":"101","author":"Dahan","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.xphs.2018.07.017_bib62","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1208\/s12248-012-9337-6","article-title":"The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs","volume":"14","author":"Dahan","year":"2012","journal-title":"AAPS J"},{"issue":"1-3","key":"10.1016\/j.xphs.2018.07.017_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/js950285r","article-title":"Correlation of drug absorption with molecular surface properties","volume":"85","author":"Palm","year":"1996","journal-title":"J\u00a0Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2018.07.017_bib65","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1023\/A:1012188625088","article-title":"Polar molecular surface properties predict the intestinal absorption of drugs in humans","volume":"14","author":"Palm","year":"1997","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.017_bib66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","article-title":"BDDCS applied to over 900 drugs","volume":"13","author":"Benet","year":"2011","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-5173(90)90103-B","article-title":"Thermodynamics of partitioning in the n-octanol\/water system of some \u03b2-blockers","volume":"63","author":"Burgot","year":"1990","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.017_bib68","first-page":"159","article-title":"A\u00a0comparison of theoretical methods of calculation of partition coefficients for selected drugs","volume":"63","author":"Pyka","year":"2006","journal-title":"Acta Pol Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2018.07.017_bib69","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J\u00a0Med Chem"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.017_bib70","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1208\/s12248-015-9743-7","article-title":"Applying Biopharmaceutical Classification System (BCS) criteria to predict oral absorption of drugs in dogs: challenges and pitfalls","volume":"17","author":"Papich","year":"2015","journal-title":"AAPS J"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01060026","article-title":"Quantitaton of rate of gastrointestinal and buccal absorption of acidic and basic drugs based on extraction theory","volume":"1","author":"Wagner","year":"1973","journal-title":"J\u00a0Pharmacokinet Biopharm"},{"key":"10.1016\/j.xphs.2018.07.017_bib72","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2013.10.015","article-title":"Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs","volume":"57","author":"Bergstrom","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.017_bib73","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejps.2013.05.019","article-title":"In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim","volume":"49","author":"Sjogren","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2018.07.017_bib74","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2165\/00003088-200241110-00005","article-title":"Theoretical predictions of drug absorption in drug discovery and development","volume":"41","author":"Stenberg","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib75","first-page":"75","article-title":"In\u00a0vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in\u00a0vitro preclinical data and clinical outcome","volume":"7","author":"Sun","year":"2004","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"1","key":"10.1016\/j.xphs.2018.07.017_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.1.1.1","article-title":"From in\u00a0vivo to in\u00a0vitro\/in silico ADME: progress and challenges","volume":"1","author":"Van de Waterbeemd","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"10.1016\/j.xphs.2018.07.017_bib77","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/jps.23977","article-title":"Biowaiver monographs for immediate-release solid oral dosage forms: codeine phosphate","volume":"103","author":"Dahan","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.07.017_bib78","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejps.2013.11.007","article-title":"The complexity of intestinal permeability: assigning the correct BCS classification through careful data interpretation","volume":"61","author":"Zur","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"1-3","key":"10.1016\/j.xphs.2018.07.017_bib79","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.017_bib80","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF01316488","article-title":"Role of villous surface area in absorption. Science versus religion","volume":"38","author":"Strocchi","year":"1993","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.xphs.2018.07.017_bib81","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/mp0499104","article-title":"Permeability dominates in\u00a0vivo intestinal absorption of P-gp substrate with high solubility and high permeability","volume":"2","author":"Cao","year":"2005","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2018.07.017_bib82","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918304520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918304520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:27:02Z","timestamp":1758360422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918304520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0022354918304520"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.07.017","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In\u00a0Vivo Permeability Values","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}